AI-designed drug appears to turn back the body's biological clock in early trial

AITopTools Editorial TeamSeptember 7, 2026

What changed

A Nature Biotechnology study reports that rentosertib, a drug designed with AI by Insilico Medicine, may reverse some markers linked to biological aging. In a trial of 42 patients, six aging measures estimated that treated participants were biologically up to six years younger than those given a placebo, but the drug has not been tested in healthy people.

What this means for you

The findings are early research, not an available anti-aging treatment. The small trial means people should not assume the drug can extend healthy lifespan or is ready for general use.

Related AI tools

Explore directory listings connected to the products, companies, and workflows in this story.

Replace Car Background magically-SpyneAI Adobe Remove Background SocialBook Background Remover TurnCage

Related AI news

AI companiesSep 8, 2026

The Work Now Within Reach

The feed does not identify a new product, release date, or access terms. Its practical message is that lower-cost AI could help individuals and businesses take on more work, but the specific tools and savings are not described.

OpenAI NewsSee why it matters

New AI featuresSep 8, 2026

This AI entrepreneur is developing agents that can plan ahead for the unexpected

There is no public tool to use yet, so the immediate takeaway is limited. The work points to a possible future generation of AI software that can adapt when plans change, but its capabilities, availability, and cost are unknown.

MIT Technology Review AISee why it matters

New AI featuresSep 7, 2026

OpenBMB Releases MiniCPM5-2B: A 2.52B Dense Model Averaging 53.9 Across 34 Benchmarks and Built to Run On Device

Developers can download and run the model locally through tools including Ollama, llama.cpp, vLLM, SGLang, and MLX, without changing the model code. Its relatively small file size may make local use more practical, though the feed does not state which consumer devices can run it or how fast it will be.

MarkTechPostSee why it matters